Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06382467
PHASE4

Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM

Sponsor: Chung-Ang University Gwangmyeong Hospital

View on ClinicalTrials.gov

Summary

This study aims to compare total intravenous anesthetic agents: combined remimazolam and propofol vs. propofol monotherapy. The comparison parameters are intraoperative hypotension, patient's involuntary movement, neurophysiological monitoring quality, onset time, recovery time, and postoperative rescue anti-emetics requirements.

Official title: Comparison of Remimazolam and Propofol Combination vs. Propofol in Intraoperative Neurophysiologic Monitoring: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2024-05

Completion Date

2025-06

Last Updated

2024-04-24

Healthy Volunteers

No

Interventions

DRUG

Remimazolam besylate + propofol MCT

remimazolam besylate 3mg/kg/hr for induction, and 0.5 mg/kg/hr for maintenance + propofol MCT 1-4 mcg/ml using target-controlled infusion

DRUG

Propofol MCT

Propofol MCT 2-8 mcg/ml using target-controlled infusion